NC
Neurocompute
AI-powered research intelligence
 Partner With Us →
Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 39,205 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

Explore Platform → See latest papers
39,205 Papers indexed
1,440 Papers AI scored
39,205 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.
LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-10-13 09:15 AM
1 Private Equity in Orthopaedics: An Analysis of Practice Acquisitions, 2016 to 2023. JB & JS open access — Oct 13, 2026 2 Plasma proteomic signatures in bipolar disorder and their implications for data-driven patient stratification. Brain, behavior, and immunity — Oct 13, 2026 3 Ventilation Strategies in a Pediatric Patient Undergoing Resection and Anastomosis for a Juxta Carinal Tumor. Annals of cardiac anaesthesia — Oct 13, 2026 4 Understanding and clinical approach to early T-cell precursor acute lymphoblastic leukemia. Blood research — Oct 13, 2026 5 Cancer history, rural residence, and genetic cancer risk testing engagement among U.S. adults. Cancer causes & control : CCC — Oct 13, 2026 6 Neighborhood socioeconomic opportunity and clinical presentation, recurrence, and longitudinal treatment intensity in adolescent pilonidal disease. Pediatric surgery international — Oct 13, 2026 7 CT-guided methylene blue staining to facilitate thoracoscopic resection of intermediate-to-deep pulmonary metastases in pediatric patients. Pediatric surgery international — Oct 13, 2026 8 Bone and Soft Tissue Neoplasms in Infants Versus Older Children: A Report From the Cancer in Young People in Canada Program. Pediatric blood & cancer — Oct 13, 2026
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

39205 results
C
Oncologic and pregnancy outcomes of fertility-sparing treatment with medroxyprogesterone acetate in women with premalignant and malignant endometrial lesions: A case series.
PMID 39765374 Published: 2024-12-30 Ingested: 2026-08-02 12:03 AM European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
AI -
Standard 61.54
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 61.5/100. Study design: 45.0; human relevance: 85.0; therapeutic relevance: 50.2; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

C
Inhibition of discoidin domain receptor 1 as a new therapeutic strategy for osteosarcoma.
PMID 39641588 Published: 2024-12-15 Ingested: 2026-08-02 12:03 AM FASEB journal : official publication of the Federation of American Societies for Experimental Biology
AI -
Standard 61.54
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 61.5/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 80.2; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Innovative pan-tumor target strategy for CAR-T therapy: cancer-specific exons as novel targets for pediatric solid and brain tumors.
PMID 39533264 Published: 2024-11-12 Ingested: 2026-08-02 12:02 AM Journal of translational medicine
AI -
Standard 61.54
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 61.5/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 80.2; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Curcumin and Methotrexate: A Promising Combination for Osteosarcoma Treatment via Hedgehog Pathway Inhibition.
PMID 39457084 Published: 2024-10-21 Ingested: 2026-08-02 12:02 AM International journal of molecular sciences
AI -
Standard 61.54
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 61.5/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 80.2; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Synaptic vesicle protein 2-targeted doxorubicin-loaded liposome for effective neuroblastoma therapy.
PMID 39413621 Published: 2024-10-16 Ingested: 2026-08-02 12:02 AM Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
AI -
Standard 61.54
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 61.5/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 80.2; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Modeling high-risk Wilms tumors enables the discovery of therapeutic vulnerability.
PMID 39368485 Published: 2024-10-04 Ingested: 2026-08-02 12:02 AM Cell reports. Medicine
AI -
Standard 61.54
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 61.5/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 80.2; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Heterogeneous SSTR2 target expression and a novel KIAA1549::BRAF fusion clone in a progressive metastatic lesion following 177Lutetium-DOTATATE molecular radiotherapy in neuroblastoma: a case report.
PMID 39324010 Published: 2024-09-11 Ingested: 2026-08-02 12:02 AM Frontiers in oncology
AI -
Standard 61.54
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 61.5/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 77.7; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

C
Medulloblastoma-associated mutations in the RNA helicase DDX3X/DED1 cause defects in the translational response to TORC1 inhibition.
PMID 42759659 Published: 2026-09-18 Ingested: 2026-09-20 09:15 AM The Journal of biological chemistry
AI -
Standard 61.52
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 61.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 30.1; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
Sociodemographic differences in long-term survival among children and young people with life-limiting conditions: A 10-year cohort analysis using national health insurance data.
PMID 42542808 Published: 2026-07-31 Ingested: 2026-08-04 09:15 AM Palliative care and social practice
AI -
Standard 61.52
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 61.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 30.1; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
IL7-Receptor-Targeted CAR T-Cell Therapy for T-Cell Acute Lymphoblastic Leukemia.
PMID 42457686 Published: 2026-07-15 Ingested: 2026-08-02 12:07 AM Nature communications
AI -
Standard 61.52
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 61.5/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 75.1; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Radiologic response assessment in patients with desmoid-type fibromatosis treated with percutaneous cryoablation.
PMID 42384128 Published: 2026-07-01 Ingested: 2026-08-02 12:07 AM European radiology experimental
AI -
Standard 61.52
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 61.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 30.1; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
Retinoblastoma in Kazakhstan: Incidence Trends and Survival Analysis (2015-2024).
PMID 42325541 Published: 2026-04-28 Ingested: 2026-08-02 12:06 AM Ocular oncology and pathology
AI -
Standard 61.52
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 61.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 30.1; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

Previous
Page 1581 of 3268
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.
Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic